-
C648970-1mgCBP/p300-IN-10 is a highly potent histone acetyltransferase EP300 and CREBBP with IC 50 values of 26 nM and 39 nM, respectively. CBP/p300-IN-10 can be used to research anticancerIn VitroCBP/p300-IN-10 (example 84) (0-1 μM: 3 h) inhibit H3K27Ac
-
C648970-5mgCBP/p300-IN-10 is a highly potent histone acetyltransferase EP300 and CREBBP with IC 50 values of 26 nM and 39 nM, respectively. CBP/p300-IN-10 can be used to research anticancerIn VitroCBP/p300-IN-10 (example 84) (0-1 μM: 3 h) inhibit H3K27Ac
-
C650999-1mgCBP/p300-IN-12 is a potent and selective covalent histone acetyltransferases p300 ( IC 50 of 166 nM) and CBP inhibitor. CBP/p300-IN-12 decreases the levels of H3K27Ac of PC-3 cells (EC 50 of 37 nM). CBP/p300-IN-12 forms a covalent adduct with
-
C650999-5mgCBP/p300-IN-12 is a potent and selective covalent histone acetyltransferases p300 ( IC 50 of 166 nM) and CBP inhibitor. CBP/p300-IN-12 decreases the levels of H3K27Ac of PC-3 cells (EC 50 of 37 nM). CBP/p300-IN-12 forms a covalent adduct with
-
C649031-10mgCBP/p300-IN-8 is a potent inhibitor of the CBP/P300 family of bromodomains . CBP/p300-IN-8 inhibits CBP ( IC 50 =0.01-0.1 µΜ) and BRD4 ( IC 50 =1-1000 µΜ) activityForm:SolidIC50&: Target:CBP 0.01-0.1 μM (IC 50 ) BRD4 1-1000 μM (IC 50 ).
-
C649031-50mgCBP/p300-IN-8 is a potent inhibitor of the CBP/P300 family of bromodomains . CBP/p300-IN-8 inhibits CBP ( IC 50 =0.01-0.1 µΜ) and BRD4 ( IC 50 =1-1000 µΜ) activityForm:SolidIC50&: Target:CBP 0.01-0.1 μM (IC 50 ) BRD4 1-1000 μM (IC 50 ).
-
C649031-5mgCBP/p300-IN-8 is a potent inhibitor of the CBP/P300 family of bromodomains . CBP/p300-IN-8 inhibits CBP ( IC 50 =0.01-0.1 µΜ) and BRD4 ( IC 50 =1-1000 µΜ) activityForm:SolidIC50&: Target:CBP 0.01-0.1 μM (IC 50 ) BRD4 1-1000 μM (IC 50 ).
-
C649204-100mgCBR-470-1 is an inhibitor of the glycolytic enzyme phosphoglycerate kinase 1 (PGK1) . CBR-470-1 is also a non-covalent Nrf2 activator. CBR-470-1 protects SH-SY5Y neuronal cells against MPP + -induced cytotoxicity through activation of the Keap1-Nrf2
-
C649204-10mgCBR-470-1 is an inhibitor of the glycolytic enzyme phosphoglycerate kinase 1 (PGK1) . CBR-470-1 is also a non-covalent Nrf2 activator. CBR-470-1 protects SH-SY5Y neuronal cells against MPP + -induced cytotoxicity through activation of the Keap1-Nrf2
-
C649204-25mgCBR-470-1 is an inhibitor of the glycolytic enzyme phosphoglycerate kinase 1 (PGK1) . CBR-470-1 is also a non-covalent Nrf2 activator. CBR-470-1 protects SH-SY5Y neuronal cells against MPP + -induced cytotoxicity through activation of the Keap1-Nrf2
-
C649204-50mgCBR-470-1 is an inhibitor of the glycolytic enzyme phosphoglycerate kinase 1 (PGK1) . CBR-470-1 is also a non-covalent Nrf2 activator. CBR-470-1 protects SH-SY5Y neuronal cells against MPP + -induced cytotoxicity through activation of the Keap1-Nrf2
-
C649204-5mgCBR-470-1 is an inhibitor of the glycolytic enzyme phosphoglycerate kinase 1 (PGK1) . CBR-470-1 is also a non-covalent Nrf2 activator. CBR-470-1 protects SH-SY5Y neuronal cells against MPP + -induced cytotoxicity through activation of the Keap1-Nrf2